
Hot flashes, sleep changes and mood symptoms are common parts of the perimenopause and menopause conversation. Eye comfort and vision often are not. Yet some patients notice burning, watering, fluctuating clarity or new difficulty wearing contact lenses during the same stage of life.
Hormones can influence the tear film, oil-producing eyelid glands and cornea, but the relationship is complex. Symptoms should not automatically be blamed on menopause, and an eye complaint alone is not a reason to start, stop or change estrogen, progesterone, testosterone or another systemic therapy.
For people seeking information about menopause and dry eye in Cincinnati, the practical first step is to identify what is actually happening on the ocular surface.
The tear film is more than water. Its oil, water and mucin components must work together to keep the eye smooth and vision stable. Sex-hormone receptors are present in ocular tissues, and hormones can affect inflammation, tear production and the meibomian glands that supply the tear film’s protective oil layer.
The TFOS DEWS II report on sex, gender and hormones explains that androgens, estrogens and other hormones help regulate the ocular surface. It also emphasizes that age, immune health, medications and many nonhormonal factors influence dry-eye risk.
Symptoms worth discussing include:
burning, grittiness or stinging;
watery eyes, especially outdoors;
fluctuating vision that improves after blinking;
contact lenses that become uncomfortable earlier in the day;
redness or tired-feeling eyes; and
increased sensitivity to wind, heating, air conditioning or screens.
The Menopause Society has highlighted dry eye during the menopause transition, while also noting that aging, autoimmune disease, smoking, medication use and contact-lens wear may contribute. That is why a personalized examination matters.
Changing estrogen and progesterone levels may affect corneal shape, tear production and eyelid oil glands. The American Academy of Ophthalmology’s hormone-and-vision overview notes that hormonal changes can be associated with dryness, temporary refractive fluctuation and contact-lens difficulty.
Research on menopausal hormone therapy and dry eye is mixed. A meta-analysis of randomized trials found improvement in one tear-production measure but not consistent improvement in tear stability or comfort. A more recent observational ARVO analysis of hormone therapy and dry-eye diagnoses found an association with higher dry-eye risk, but association does not establish that the therapy caused the condition.
The patient-friendly takeaway is simple: hormone therapy should not be prescribed as a dry-eye treatment, and it should not be stopped because of dry eye without coordination with the clinician managing menopause care.
Androgens, including testosterone, appear to support meibomian-gland function. Low androgen activity has been studied as one possible contributor to evaporative dry eye. However, that does not mean systemic testosterone is an established treatment for routine dry eye.
A small randomized pilot study of transdermal testosterone and estrogen illustrates why careful language is necessary: hormone effects can differ by treatment, dose, tissue and patient, and limited studies cannot support a universal recommendation.
Patients may receive testosterone for several reasons, including menopausal sexual-health concerns, documented androgen deficiency or gender-affirming care. Bring the exact medication, formulation and dose to the eye examination. The eye doctor’s role is to evaluate symptoms and ocular findings, then communicate with the prescribing clinician when coordination would help.
The Menopause Society’s hormone-therapy guide distinguishes systemic therapy from low-dose local therapy and explains that estrogen may be used alone or with a progestogen depending on the patient’s circumstances. Compounded products and commercially approved medications are not automatically interchangeable.
From an eye-care perspective, useful details include:
the active ingredients and whether therapy is systemic or local;
when it started and whether the dose recently changed;
whether symptoms began before or after the change;
other medicines that may promote dryness; and
autoimmune, thyroid, diabetes or migraine history.
Do not assume every midlife symptom is hormonal. Allergy, blepharitis, meibomian-gland dysfunction, medication effects, contact-lens complications and other eye disease can feel similar.
At a comprehensive eye examination, Dr. Baik may assess the prescription, cornea, lens, retina and optic nerve while reviewing medical and medication history. When dryness is the main concern, a focused dry-eye evaluation may also examine:
blink quality and eyelid closure;
tear-film stability;
corneal and conjunctival staining;
lash-line inflammation;
meibomian-gland function; and
environmental, screen and contact-lens triggers.
The AAO dry-eye clinical guideline supports using history plus multiple examination findings because no single test explains every patient’s symptoms.
Depending on the diagnosis, care may include preservative-free lubrication, a lipid-supporting drop, eyelid hygiene, a properly heated mask, prescription medication or an in-office treatment for selected ocular-surface disease. See Well also offers advanced options described on our dry-eye treatment page, but no procedure is right for everyone.
If a specific drop, warming product or supplement is recommended, purchasing it through See Well keeps the product choice, instructions and troubleshooting connected to the examination. That is useful because “menopause support” marketing is not the same as evidence-based eye care. Buying from the practice does not guarantee a medical result, and we do not recommend the same product to every patient.
Contact-lens comfort can change even when the prescription appears stable. Tear evaporation, deposits, lens material, fit and replacement schedule all matter. A contact-lens examination allows the lens to be evaluated on the eye instead of treating discomfort as a brand preference.
Possible solutions may include a different material or replacement schedule, daily disposable lenses, modified wear time, dry-eye treatment or more frequent use of glasses. When a lens is prescribed and purchased through See Well, the exact prescription, manufacturer supply, rebates when available, shipping and follow-up remain connected to the team that examined the eye.
Seek prompt evaluation for persistent blur, eye pain, marked redness, light sensitivity, new flashes or floaters, a curtain over vision, or vision loss in one or both eyes. Sudden vision change with weakness, facial droop, severe headache, speech difficulty or imbalance requires emergency medical evaluation.
Our emergency eye-care guidance can help patients understand when to contact the office and when the emergency department is the safer destination.
See Well Eyecare is located in Hyde Park (45208), convenient to Oakley (45209), Mariemont (45227) and nearby Mount Lookout. We welcome adults looking for a Hyde Park optometrist who can connect new symptoms with the complete medical, medication and visual picture.
Pair an appointment with a gentle walk at Ault Park, browse the seasonal calendar for Hyde Park Square, or enjoy the galleries and current programs at the Cincinnati Art Museum. Outdoor wind and indoor climate control can both reveal dry-eye symptoms, so bring sunglasses and use only eye drops recommended for your situation.
Menopause is associated with a higher likelihood of dry-eye symptoms, but it is rarely the only possible contributor. Age, medications, autoimmune disease, allergy, screens and eyelid-gland dysfunction also matter.
Research is mixed, and responses differ. Do not start or stop estrogen because of eye symptoms without discussing the full risks and benefits with the prescribing clinician.
Androgens influence meibomian-gland biology, but systemic testosterone is not a standard universal treatment for dry eye. An eye examination should first identify the type and severity of ocular-surface disease.
Hormonal change may contribute, but lens fit, material, deposits, wear time, allergy and dry eye can produce similar symptoms. A contact-lens evaluation can distinguish among them.
Not necessarily. Persistent or functionally important blur deserves an examination. If the prescription is fluctuating, the doctor can explain whether monitoring or an updated lens is more appropriate.
Use See Well’s appointment-request page and mention dryness, fluctuating vision, contact-lens discomfort and any recent hormone-therapy changes.
Rawzi Baik, OD, is the owner and optometrist at See Well Eyecare in Hyde Park, Cincinnati. A graduate of The Ohio State University College of Optometry, he provides comprehensive and medical eye care with an emphasis on clear education, modern diagnostic technology and individualized treatment.
If your eyes feel different during perimenopause, menopause or hormone therapy, you do not have to guess whether the cause is “normal.” Schedule an evaluation, bring a complete medication list and let the findings guide the plan.
Primary keyword: menopause dry eye Cincinnati
Supporting keywords: perimenopause vision changes, hormone therapy eyes, estrogen dry eye, testosterone eye effects, contact lenses menopause, Hyde Park eye doctor